Cancer-Attributable Mortality Among People With Treated Human Immunodeficiency Virus Infection in North America
暂无分享,去创建一个
Richard D Moore | J. Goedert | B. Lau | K. Anastos | Jeffrey N. Martin | P. Harrigan | B. Yip | R. Hogg | J. Montaner | S. Gange | J. Willig | S. Boswell | R. Pfeiffer | W. Lober | K. Buchacz | J. Brooks | T. Sterling | D. Haas | M. Gill | M. Mugavero | M. Saag | R. Bosch | S. Rourke | A. Justice | M. Horberg | P. Rebeiro | Julia Zhu | K. Sigel | K. Mayer | Karyn Gabler | S. Deeks | K. Gebo | E. Engels | A. Rachlis | C. Benson | J. Eron | D. Fiellin | M. Kitahata | B. Rodriguez | G. Kirk | J. Globerman | A. Abraham | H. Crane | M. Silverberg | L. Jacobson | C. Grasso | S. Grover | M. Shiels | C. Rabkin | M. Klein | P. Patel | G. D’Souza | J. McReynolds | J. Thorne | B. Liu | R. Dubrow | K. Althoff | M. Turner | S. Napravnik | A. Mayor | R. McKaig | J. Carey | Stephen E. Van Rompaey | E. Yanik | K. Salters | S. Modur | S. Bebawy | Jinbing Zhang | B. Hogan | D. Drozd | L. Park | R. Hunter-Mellado | Aimee M. Freeman | Ben Rogers | Cherise Wong | W. Wheeler | Madison Kopansky-Giles | Carol Lent | Liz Morton | Jerry Jing | Fidel A Desir | Bin You | William Lober | S. V. Van Rompaey
[1] Richard D Moore,et al. Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] J. Efstathiou,et al. HIV Infection and Survival Among Women With Cervical Cancer. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] B. Milleron,et al. Lung Cancer Screening with Chest Computed Tomography in People Living with HIV: A Review by the Multidisciplinary CANCERVIH Working Group , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[4] S. Himelhoch,et al. Behavioral Interventions for Tobacco Use in HIV-Infected Smokers: A Meta-Analysis , 2016, Journal of acquired immune deficiency syndromes.
[5] A. Jemal,et al. Disparities in cancer treatment among patients infected with the human immunodeficiency virus , 2016, Cancer.
[6] K. Crothers,et al. Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS: a meta-analysis , 2016, AIDS.
[7] Richard D Moore,et al. Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study. , 2015, Annals of internal medicine.
[8] E. Engels,et al. Elevated Cancer-Specific Mortality Among HIV-Infected Patients in the United States. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] R. Pfeiffer,et al. Excess cancers among HIV-infected people in the United States. , 2015, Journal of the National Cancer Institute.
[10] J. Skarbinski,et al. Cigarette Smoking Prevalence Among Adults With HIV Compared With the General Adult Population in the United States , 2015, Annals of Internal Medicine.
[11] D. Klein,et al. Survival among HIV-Infected and HIV-Uninfected Individuals with Common Non–AIDS-Defining Cancers , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[12] J. Margolick,et al. The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation , 2015, AIDS.
[13] Richard D Moore,et al. Incidence and risk factors of HPV-related and HPV-unrelated Head and Neck Squamous Cell Carcinoma in HIV-infected individuals. , 2014, Oral oncology.
[14] O. Kirk,et al. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration , 2014, The Lancet.
[15] P. Morlat,et al. Causes of death among HIV-infected patients in France in 2010 (national survey): trends since 2000 , 2014, AIDS.
[16] J. Sterne,et al. Impact of Risk Factors for Specific Causes of Death in the First and Subsequent Years of Antiretroviral Therapy Among HIV-Infected Patients , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] R. Pfeiffer,et al. Epidemiologic contributions to recent cancer trends among HIV-infected people in the United States , 2014, AIDS.
[18] James J. Goedert,et al. Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada , 2013, PloS one.
[19] Richard D Moore,et al. Invasive Cervical Cancer Risk Among HIV-Infected Women: A North American Multicohort Collaboration Prospective Study , 2013, Journal of acquired immune deficiency syndromes.
[20] R. Weber,et al. Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study , 2013, HIV medicine.
[21] E. Simard,et al. Mortality due to cancer among people with AIDS: a novel approach using registry-linkage data and population attributable risk methods , 2012, AIDS.
[22] Richard D Moore,et al. Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[23] J. Goedert,et al. Cancer burden in the HIV-infected population in the United States. , 2011, Journal of the National Cancer Institute.
[24] Aliza K Fink,et al. The accuracy of cancer mortality statistics based on death certificates in the United States. , 2011, Cancer epidemiology.
[25] A. Mariotto,et al. Improved estimates of cancer-specific survival rates from population-based data. , 2010, Journal of the National Cancer Institute.
[26] Ross J. Harris,et al. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[27] M. King,et al. Serum immune activation markers are persistently increased in patients with HIV infection after 6 years of antiretroviral therapy despite suppression of viral replication and reconstitution of CD4+ T cells. , 2009, The Journal of infectious diseases.
[28] C. Sabin,et al. Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy , 2009, AIDS.
[29] Anne M Johnson,et al. Changes in the risk of death after HIV seroconversion compared with mortality in the general population. , 2008, JAMA.
[30] J. Goedert,et al. Cancer risk in people infected with human immunodeficiency virus in the United States , 2008, International journal of cancer.
[31] F. Schmidt. Meta-Analysis , 2008 .
[32] Richard D Moore,et al. Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). , 2007, International journal of epidemiology.
[33] Jeffrey N. Martin,et al. T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. , 2003, The Journal of infectious diseases.
[34] M. Weinstein,et al. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. , 1999, JAMA.
[35] C. Weinberg,et al. Use and misuse of population attributable fractions. , 1998, American journal of public health.